Friday - May 1, 2026
Virginia Tech: Blocking Two Proteins Reverses Lung Scarring in Preclinical Study
May 01, 2026
BLACKSBURG, Virginia, May 1 (TNSjou) -- Virginia Tech issued the following news:

* * *

Blocking two proteins reverses lung scarring in preclinical study

A multi-institutional team identifies new approach that could move beyond delaying pulmonary fibrosis to reversing lung scarring.

By John Pastor

A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing that blocking . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products